Emine Bayraktar

Publication Activity (10 Years)

Years Active: 2020-2021
Publications (10 Years): 3

Top Topics

Top Venues

Molecular cancer therapeutics

Molecular cancer research : MCR

This page only lists publications with an associated author ORCID identifier.

Publications

Michael H McGuire, Santosh K Dasari, Hui Yao, Yunfei Wen, Lingegowda S Mangala, Emine Bayraktar, Wencai Ma, Cristina Ivan, Einav Shoshan, Sherry Y Wu, Eric Jonasch, Menashe Bar-Eli, Jing Wang, Keith A Baggerly, Anil K Sood
Gene Body Methylation of the Lymphocyte-Specific Gene CARD11 Results in Its Overexpression and Regulates Cancer mTOR Signaling. Molecular cancer research : MCR 19 (11) (2021)
Katelyn F Handley, Cristian Rodríguez-Aguayo, Shaolin Ma, Elaine Stur, Robiya Joseph, Emine Bayraktar, Santosh K Dasari, Nghi Nguyen, Reid T Powell, Mary Sobieski, Cristina Ivan, Mark Kim, Sujanitha Umamaheswaran, Deanna M Glassman, Yunfei Wen, Paola Amero, Clifford Stephen, Robert L Coleman, Yosef Landesman, Shannon Neville Westin, Prahlad T Ram, Anil K Sood
Rational Combination of CRM1 Inhibitor Selinexor and Olaparib Shows Synergy in Ovarian Cancer Cell Lines and Mouse Models. Molecular cancer therapeutics 20 (12) (2021)
Takahito M Miyake, Sunila Pradeep, Emine Bayraktar, Elaine Stur, Katelyn F Handley, Sherry Y Wu, Cristian Rodríguez-Aguayo, Ju-Seog Lee, Gabriel Lopez-Berestein, Robert L Coleman, Anil K Sood
NRG1/ERBB3 Pathway Activation Induces Acquired Resistance to XPO1 Inhibitors. Molecular cancer therapeutics 19 (8) (2020)